Logos Global Management’s Apellis Pharmaceuticals APLS Stock Holding History

Logos Global Management’s Portfolio APLS Stock Details APLS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-500,000	Closed	-$16M	–	42
2024 Q4	$16M	Buy	+500,000	New	+$15M	1.87%	20
2024 Q3	–	Sell	-400,000	Closed	-$14.8M	–	57
2024 Q2	$15.3M	Sell	400,000 -400,000	-50%	-$18.1M	1.23%	22
2024 Q1	$47M	Sell	800,000 -150,000	-16%	-$9.56M	3.81%	10
2023 Q4	$56.9M	Buy	950,000 +200,000	+27%	+$10.1M	5.31%	5
2023 Q3	$28.5M	Buy	750,000 +125,000	+20%	+$5.49M	3.81%	7
2023 Q2	$56.9M	Sell	625,000 -175,000	-22%	-$15.1M	7.74%	1
2023 Q1	$52.8M	Sell	800,000 -550,000	-41%	-$31.7M	7.55%	1
2022 Q4	$69.8M	Buy	1,350,000 +50,000	+4%	+$2.65M	8.18%	2
2022 Q3	$88.8M	Sell	1,300,000 -200,000	-13%	-$11.8M	10.92%	1
2022 Q2	$67.8M	Buy	1,500,000 +600,000	+67%	+$27.4M	12.44%	2
2022 Q1	$45.7M	Sell	900,000 -100,000	-10%	-$4.41M	5.93%	3
2021 Q4	$47.3M	Sell	1,000,000 -450,000	-31%	-$17.7M	4.88%	5
2021 Q3	$47.8M	Buy	1,450,000 +1,100,000	+314%	+$61.8M	3.45%	8
2021 Q2	$22.1M	Buy	+350,000	New	+$18.1M	1.86%	20
2021 Q1	–	Sell	-300,000	Closed	-$17.2M	–	55
2020 Q4	$17.2M	Buy	+300,000	New	+$12.7M	1.47%	13
2020 Q1	–	Sell	-587,108	Closed	-$18M	–	43
2019 Q4	$18M	Buy	+587,108	New	+$16.2M	4.43%	7

Other funds holding APLS

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

PCM

Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

DTC

Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return

Logos Global Management's APLS Position: Q1 2025 in Review

Logos Global Management sold out of Apellis Pharmaceuticals (APLS) in Q1 2025, closing a stake of 500,000 shares — an estimated $16M sold.

Logos Global Management first reported a position in APLS in Q4 2019 and held it in 16 quarters. The position peaked at $88.8M in Q3 2022. 255 funds tracked by Wall St. Rank hold APLS as of Q1 2025.

Logos Global Management reported no remaining Apellis Pharmaceuticals position as of Q1 2025 after selling out during the quarter.
Logos Global Management sold 500,000 Apellis Pharmaceuticals shares in Q1 2025, an estimated $16M.
Logos Global Management first reported a position in Apellis Pharmaceuticals in Q4 2019 and held it in 16 quarters.
Logos Global Management's Apellis Pharmaceuticals position peaked at $88.8M in Q3 2022.
255 funds tracked by Wall St. Rank held Apellis Pharmaceuticals as of Q1 2025.

Based on Logos Global Management's 13F filing for Q1 2025, filed 15 May 2025.